Adverse events42

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 42

Type	Event	Organ system	Group	Affected	At risk	Events
other	Reactive cutaneous capillary endothelial proliferation, RCCEP	Skin and subcutaneous tissue disorders	Neoadjuvant PD-1 Blockade Alone	29	34	29
other	Reactive cutaneous capillary endothelial proliferation, RCCEP	Skin and subcutaneous tissue disorders	Neoadjuvant PD-1 Blockade Plus TPF Induction Chemotherapy	24	34	24
other	Anemia	Blood and lymphatic system disorders	Neoadjuvant PD-1 Blockade Alone	7	34	7
other	Anemia	Blood and lymphatic system disorders	Neoadjuvant PD-1 Blockade Plus TPF Induction Chemotherapy	25	34	25
other	Mucositis oral	Skin and subcutaneous tissue disorders	Neoadjuvant PD-1 Blockade Alone	6	34	6
other	Mucositis oral	Skin and subcutaneous tissue disorders	Neoadjuvant PD-1 Blockade Plus TPF Induction Chemotherapy	8	34	8
other	Creatinine increased	Renal and urinary disorders	Neoadjuvant PD-1 Blockade Alone	6	34	6
other	Creatinine increased	Renal and urinary disorders	Neoadjuvant PD-1 Blockade Plus TPF Induction Chemotherapy	15	34	15
other	GGT increased	Hepatobiliary disorders	Neoadjuvant PD-1 Blockade Alone	4	34	4
other	GGT increased	Hepatobiliary disorders	Neoadjuvant PD-1 Blockade Plus TPF Induction Chemotherapy	5	34	5
other	Vomiting	Gastrointestinal disorders	Neoadjuvant PD-1 Blockade Alone	0	34	0
other	Vomiting	Gastrointestinal disorders	Neoadjuvant PD-1 Blockade Plus TPF Induction Chemotherapy	10	34	10
other	Alopecia	Skin and subcutaneous tissue disorders	Neoadjuvant PD-1 Blockade Alone	0	34	0
other	Alopecia	Skin and subcutaneous tissue disorders	Neoadjuvant PD-1 Blockade Plus TPF Induction Chemotherapy	28	34	28
other	Lymphocyte count decreased	Blood and lymphatic system disorders	Neoadjuvant PD-1 Blockade Alone	5	34	5
other	Lymphocyte count decreased	Blood and lymphatic system disorders	Neoadjuvant PD-1 Blockade Plus TPF Induction Chemotherapy	13	34	13
other	Platelet count decreased	Blood and lymphatic system disorders	Neoadjuvant PD-1 Blockade Alone	0	34	0
other	Platelet count decreased	Blood and lymphatic system disorders	Neoadjuvant PD-1 Blockade Plus TPF Induction Chemotherapy	3	34	3
other	Blood lactate dehydrogenase increased	Hepatobiliary disorders	Neoadjuvant PD-1 Blockade Alone	2	34	2
other	Blood lactate dehydrogenase increased	Hepatobiliary disorders	Neoadjuvant PD-1 Blockade Plus TPF Induction Chemotherapy	9	34	9

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04649476/events

API reference For AI assistants

Adverse events42

Sources 3

Read this list from software.